Metabolic Dysfunction-Associated Steatotic Liver Disease MASLD: Jordan's Perspective Based on Knowledge and Attitude Determinants

被引:0
作者
Alqudah, Omar [1 ]
Alshahwan, Hamzeh Feras [2 ]
Alsamhouri, Jehad Feras [2 ]
Yamin, Saif [2 ]
Kaffaf, Ahmad [2 ]
Alassaf, Mohannad [2 ]
Alwarawrah, Zaid [3 ]
机构
[1] Univ Jordan, Jordan Univ Hosp & Sch Med, Dept Med, Div Hepatol & Gastroenterol, Amman, Jordan
[2] Univ Jordan, Sch Med, Amman, Jordan
[3] Mutah Univ, Sch Med, Al Karak, Jordan
关键词
nonalcoholic fatty liver disease; NAFLD; MASLD; hepatic steatosis; liver health; patient education; public health awareness; medical literacy; Metabolic Dysfunction-Associated Steatotic Liver Disease; PREVALENCE; OBESITY; RISK;
D O I
10.2147/RMHP.S481401
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: The most prevalent chronic liver disease in both developed and developing nations is Metabolic dysfunction-associated Steatotic Liver Disease (MASLD). The condition increases the risk of comorbidities and liver-related morbidity and mortality. The public's awareness and medical personnel's understanding are essential in creating countermeasures to stop the disease's spread; a positive attitude is essential for early screening. This study aimed to explore the knowledge and attitudes of Jordanians living in Amman toward MASLD to determine the public's awareness and medical personnel's understanding of the disease. Materials and Methods: A cross-sectional study was conducted using an online self-administered questionnaire that included 5 items for knowledge and 8 for attitude. Demographic questions were also included to further examine how demographic factors affected knowledge and attitude. Results: Among 906 responders, (63.4%) were females, and (36.6%) were males. The majority age group was 18-30 (56.2%). Only 49.5% had previous knowledge of MASLD, (44.6%) believed they were at risk of developing it. There is a statistical significance between age, gender, educational level, and having a good knowledge of MASLD and a positive attitude towards it (p<0.05). Conclusion: Generally, Jordan's population has a fair knowledge of MASLD and a positive attitude towards it. Warranting more research into the reasons behind it, and more awareness campaigns.
引用
收藏
页码:2483 / 2491
页数:9
相关论文
共 50 条
[41]   Lymph Node Adiposity and Metabolic Dysfunction-Associated Steatotic Liver Disease [J].
Rubino, Jessica M. ;
Ring, Natalie Yanzi ;
Patel, Krishna ;
Xia, Xiaoqing ;
Mackenzie, Todd A. ;
diFlorio-Alexander, Roberta M. .
BIOMEDICINES, 2025, 13 (01)
[42]   Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor [J].
Platek, Anna E. ;
Szymanska, Anna .
CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 9 (03) :187-192
[43]   Pathogenesis and Clinical Management of Metabolic Dysfunction-Associated Steatotic Liver Disease [J].
Lucaciu, Roxana Liana ;
Coste, Sorina Cezara ;
Hangan, Adriana Corina ;
Iancu, Mihaela ;
Orasan, Olga Hilda ;
Cozma, Angela ;
Gog Bogdan, Sidonia ;
Procopciuc, Lucia Maria .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (12)
[44]   Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [J].
Ramanathan, Raghu ;
Patwa, Sohum A. ;
Ali, Ahmad Hassan ;
Ibdah, Jamal A. .
CELLS, 2023, 12 (24)
[45]   Diagnosis and evaluation of metabolic dysfunction associated steatotic liver disease (MASLD) [J].
Canivet, C. M. ;
Faure, S. .
REVUE DE MEDECINE INTERNE, 2024, 45 (01) :41-47
[46]   Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis [J].
Malik, Adnan ;
Javaid, Sadia ;
Malik, Muhammad Imran ;
Qureshi, Shahbaz .
ANNALS OF HEPATOLOGY, 2024, 29 (06)
[47]   Clinical and Economic Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Spanish Mediterranean Region: A Population-Based Study [J].
Diaz Carnicero, Javier ;
Sauri-Ferrer, Inma ;
Redon, Josep ;
Navarro, Jorge ;
Fernandez, Gonzalo ;
Hurtado, Carlos ;
Ferreira, Karine ;
Alvarez-Ortega, Carolina ;
Gomez, Anton ;
Martos-Rodriguez, Carlos J. ;
Marti-Aguado, David ;
Escudero, Desamparados ;
Cedenilla, Marta .
JOURNAL OF CLINICAL MEDICINE, 2025, 14 (07)
[48]   Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis [J].
Bernhard, Johannes ;
Galli, Lukas ;
Speidl, Walter S. ;
Krychtiuk, Konstantin A. .
CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
[49]   Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD [J].
Abdelhameed, Farah ;
Kite, Chris ;
Lagojda, Lukasz ;
Dallaway, Alexander ;
Chatha, Kamaljit Kaur ;
Chaggar, Surinderjeet S. ;
Dalamaga, Maria ;
Kassi, Eva ;
Kyrou, Ioannis ;
Randeva, Harpal S. .
CURRENT OBESITY REPORTS, 2024, 13 (03) :510-531
[50]   Pediatricians' practices and knowledge of metabolic dysfunction-associated steatotic liver disease: An international survey [J].
Lubrecht, Judith W. ;
van Giesen, Guusje H. J. ;
Janczyk, Wojciech ;
Zavhorodnia, Olha ;
Zavhorodnia, Natalia ;
Socha, Piotr ;
Moran-Lev, Hadar ;
Vreugdenhil, Anita C. E. .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 78 (03) :524-533